Emergent Biosolutions Inc’s filing revealed that its Director Zoon Kathryn C unloaded Company’s shares for reported $61100.0 on Jun 04 ’24. In the deal valued at $6.11 per share,10,000 shares were sold. As a result of this transaction, Zoon Kathryn C now holds 54,482 shares worth roughly $0.51 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Zoon Kathryn C sold 1,830 shares, generating $8,436 in total proceeds. Upon selling the shares at $4.61, the Director now owns 64,482 shares.
Before that, Zoon Kathryn C sold 1,089 shares. Emergent Biosolutions Inc shares valued at $6,294 were divested by the Director at a price of $5.78 per share. As a result of the transaction, Zoon Kathryn C now holds 48,882 shares, worth roughly $0.46 million.
Rodman & Renshaw initiated its Emergent Biosolutions Inc [EBS] rating to a Buy in a research note published on August 22, 2024; the price target was $16. A number of analysts have revised their coverage, including The Benchmark Company’s analysts, who increased its forecast for the stock in early March from “a Hold” to “a Buy”. The Benchmark Company revised its rating on August 29, 2023. It rated EBS as “a Hold” which previously was an “a Buy”.
Price Performance Review of EBS
On Friday, Emergent Biosolutions Inc [NYSE:EBS] saw its stock jump 2.30% to $9.35. Over the last five days, the stock has gained 6.86%. Emergent Biosolutions Inc shares have risen nearly 289.58% since the year began. Nevertheless, the stocks have risen 304.76% over the past one year. While a 52-week high of $15.10 was reached on 07/30/24, a 52-week low of $1.42 was recorded on 02/06/24. SMA at 50 days reached $8.28, while 200 days put it at $5.56.
Levels Of Support And Resistance For EBS Stock
The 24-hour chart illustrates a support level at 9.02, which if violated will result in even more drops to 8.68. On the upside, there is a resistance level at 9.53. A further resistance level may holdings at 9.70. The Relative Strength Index (RSI) on the 14-day chart is 59.77, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.19, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 27.22%. Stochastics %K at 73.16% indicates the stock is a holding.
How much short interest is there in Emergent Biosolutions Inc?
A steep rise in short interest was recorded in Emergent Biosolutions Inc stocks on 2024-09-30, growing by 4.39 million shares to a total of 8.23 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 3.84 million shares. There was a rise of 53.37%, which implies that there is a positive sentiment for the stock.
